COMAI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 6.789
EU - Europa 6.183
AS - Asia 3.887
AF - Africa 489
SA - Sud America 44
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.418
Nazione #
US - Stati Uniti d'America 6.753
IT - Italia 1.502
GB - Regno Unito 1.217
CN - Cina 1.205
SG - Singapore 1.033
DE - Germania 845
SE - Svezia 749
VN - Vietnam 632
HK - Hong Kong 403
IN - India 347
FR - Francia 304
RU - Federazione Russa 287
IE - Irlanda 276
NL - Olanda 249
UA - Ucraina 230
TG - Togo 203
FI - Finlandia 150
CI - Costa d'Avorio 100
ZA - Sudafrica 98
JO - Giordania 93
BG - Bulgaria 85
EE - Estonia 85
NG - Nigeria 60
AT - Austria 53
KR - Corea 46
BE - Belgio 43
ID - Indonesia 36
BR - Brasile 34
CA - Canada 31
CH - Svizzera 31
IR - Iran 24
AU - Australia 20
PL - Polonia 16
SC - Seychelles 16
JP - Giappone 14
GR - Grecia 13
PH - Filippine 12
ES - Italia 11
TR - Turchia 9
CL - Cile 7
DK - Danimarca 6
LT - Lituania 6
SA - Arabia Saudita 6
EG - Egitto 5
HR - Croazia 5
MX - Messico 5
BD - Bangladesh 4
EU - Europa 4
PK - Pakistan 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
RO - Romania 3
UZ - Uzbekistan 3
AL - Albania 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
Totale 17.418
Città #
Southend 1.056
Singapore 907
Chandler 708
Fairfield 611
Ashburn 581
Santa Clara 407
Hong Kong 398
Wilmington 315
Ann Arbor 314
Woodbridge 299
Houston 298
Princeton 281
Dublin 273
Bologna 263
Seattle 254
Cambridge 218
Dong Ket 210
Lomé 203
Boardman 192
Jacksonville 143
Hefei 135
Helsinki 114
Westminster 113
Nanjing 107
Abidjan 100
Turin 96
Amman 93
Milan 93
Berlin 91
Padova 86
Sofia 84
Hanoi 80
Frankfurt am Main 78
Ho Chi Minh City 74
Beijing 73
Bremen 71
Florence 61
Hyderabad 61
Redmond 60
Abeokuta 59
Jinan 59
Munich 50
Medford 48
Saint Petersburg 45
New York 44
Brussels 43
Shenyang 43
Falkenstein 42
Seoul 42
Changsha 39
Los Angeles 39
Nuremberg 38
Des Moines 35
Nanchang 35
Guangzhou 34
Rome 34
Redwood City 33
Amsterdam 32
Jakarta 32
San Diego 32
Dearborn 31
Zhengzhou 31
Hebei 29
London 28
Pune 28
Tianjin 28
Vienna 28
Shanghai 23
Haikou 22
Modena 22
Mountain View 22
Phoenix 22
Turku 22
Jiaxing 21
Mülheim 20
Bern 19
Toronto 19
Lauterbourg 18
San Francisco 16
Casalecchio di Reno 15
Düsseldorf 15
Falls Church 15
Chengdu 14
Mahé 14
Olalla 14
Rimini 14
Taiyuan 14
Castel Maggiore 13
Chicago 13
Hangzhou 13
Lappeenranta 13
Naples 13
Norwalk 13
Wuhan 13
Yubileyny 13
Bühl 12
Monmouth Junction 12
Ningbo 12
Tokyo 12
Xi'an 12
Totale 11.187
Nome #
Stem Cells 275
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 222
Automatic Adaptive System Dialysis for Hemodialysis-Associated Hypotension and Intolerance: A Noncontrolled Multicenter Trial. 213
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients 211
Correlazioni tra decoy cells urinarie, viremia BK e terapia immunosoppressiva nel trapianto di rene 205
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 198
COLONIZZAZIONE ED INFEZIONE DA KLEBSIELLA PNEUOMONIAE PRODUTTRICE DI CARBAPENEMASI (KPC) NEL PAZIENTE SOTTOPOSTO A TRAPIANTO DI RENE 188
Combined liver–dual kidney transplant: Role in expanded donors 173
Combined application of Hemodiafiltration and Profiler: short and mid-term clinical results in 16 patients. 171
Delayed Graft Function (DGF) e Trapianto Renale: studio dei principali fattori di rischio. 164
Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants 158
Methylenetetrahydrofolate reductase, MTHFR, polymorphisms and predisposition to different multifactorial disorders 152
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 151
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 147
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. 146
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. 145
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 145
A case report of IgG4-related disease: an insidious path to the diagnosis through kidney, heart and brain 145
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation 143
INDICAZIONI NEFROLOGICHE AL TRAPIANTO COMBINATO RENE-FEGATO 141
Reduction of Oxidative Damage Reflects a Better Kidney Transplantation Outcome. 141
Cabozantinib-induced renal thrombotic microangiopathy 141
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 140
An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury. 140
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 139
A very early and acute renal impairment due to polyomavirus allograft nephropathy. 138
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 138
Genetic Factors and Risk OF Acute Rejection in Kidney Transplant 137
Seroprevalence of a “new” bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients 137
Impact of cytokines and apoptosis molecules polymorphisms on Chronic Allograft Nephropathy 136
Schemi di terapia immunosoppressiva e livelli ematici consigliati 136
Removal of free light chains in hemodialysis patients without multiple myeloma: A crossover comparison of three different dialyzers 136
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 134
DNA VIRAL INFECTIONS ASSAY IN KIDNEY TRANSPLANT RECIPIENTS BY A NEW HIGH THROUGHPUT MASS SPECTROMETRY METHOD 134
Nephrological indications in combined liver kidney transplantation 133
Chronic allograft dysfunction: role of immunosuppressive treatment 133
Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome 132
Impiego combinato HFR-Profiler: risultati clinici a breve-medio termine 132
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 132
Fifteen-year analysis of deceased kidney donation: A single transplant center experience in a region of northern Italy 132
Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report 129
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 128
Nephrological indications in combined liver-kidney transplantation. 127
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 127
Incidenza di Rigetto Acuto nel Trapianto Renale: ruolo dei fattori genetici 126
Predictive factors in chronic allograft nephropathy 126
Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells 125
INFLUENCE OF DELAYED GRAFT FUNCTION (DGF) ON RENAL TRANSPLANTATION OUTCOME 124
Prevenzione della trombosi dei cateteri a permanenza per emodialisi: profilassi mediante anticoagulazione con warfarin 124
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 124
Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients. 123
An in vitro model of renal inflammation after ischemic oxidative stress injury: Nephroprotective effects of a hyaluronan ester with butyric acid on mesangial cells 123
Hepatorenal syndrome: Update on diagnosis and treatment 121
Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients 120
RUOLO DELL'ISTOLOGIA NELLA DELAYED GRAFT FUNCTION 119
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus. 118
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 118
Treatment of Acute Antibody-Mediated Rejection 117
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 116
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 116
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 116
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin. 115
null 115
Score istologico pre-trapianto e outcome del trapianto renale 114
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 114
Warfarin anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters thrombosis. 113
[Membranous glomerulonephritis (MGN), ongoing studies] 112
Tyrosine-Kinase Inhibitors for Treatment in Hemodialysis Patients on Kidney Transplant Waiting List. Comment on: Nakai et al 111
Influence of delayed graft function (DGF) on renal transplantation outcome 110
Jugular vein-mammary artery fistula after catheterism for hemodialysis: case report. 109
THE USE OF 3D AUGMENTED REALITY DURING ROBOT-ASSISTED LIVING DONOR NEPHRECTOMY (RALDN): A CASE REPORT TECHNICAL OVERVIEW 109
Perfusione Continua versus Ipotermia Semplice nel Trapianto d’organo. Studio sperimentale su modello animale. 108
Outcome of kidney function in adults on long-term home parenteral nutrition for chronic intestinal failure 108
Normothermic and hypothermic oxygenated perfusion for donation after circulatory death in kidney transplantation: Do we pay higher risk of severe infection after transplantation?: A case report 108
Mycophenolate Mofetil: A Possible Alternative Treatment for IgA Nephropathy 108
Fattori di rischio genetici per la patologia cardiovascolare dopo trapianto di rene: ruolo dei polimorfismi delle citochine 107
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 107
FTY720 nel trapianto renale: caratterizzazione molecolare dei processi di homing dei linfociti circolanti 106
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 106
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy 105
Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. 104
Genetic variability and cardiovascular risk in renal transplant recipients 103
Increase in Serum Amylase and Resistive Index After Kidney Transplant Are Biomarkers of Delayed Graft Function 103
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival 102
Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys 102
Role of the hemodialysis vascular access type in inflammation status and monocyte activation. 100
Low-toxicity immunosuppressive therapy in renal transplant. [Il successo del trapianto di rene dipende anche da una terapia efficace a bassa tossicità]. 100
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 100
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 99
Kidney transplant in fabry disease: A revision of the literature 98
Reply 97
A large, international study on post-transplant glomerular diseases: The TANGO project 97
Kidney Transplant from donors after cardiac death (DCD): monocentric experience and literature review 97
Protonic pump inhibitors in kidney transplant patients: efficacy and safety 96
HCV ED ETA' AVANZATA SONO LIMITI SUPERABILI NELLA DONAZIONE DI RENE DA VIVENTE 96
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring 96
Risk for Contrast Nephropathy in Patients Undergoing Coronarography 94
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 94
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 94
Therapy strategies in the prevention of chronic allograft nephropathy 93
Totale 12.831
Categoria #
all - tutte 54.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 0 0 0 0 0 0 0 145
2020/20211.769 325 121 62 63 66 107 52 131 161 105 79 497
2021/20222.727 183 138 176 207 248 174 74 204 120 181 555 467
2022/20233.467 306 491 167 441 257 295 108 200 637 97 305 163
2023/20241.253 80 185 64 127 80 252 67 117 38 86 85 72
2024/20255.102 251 620 507 301 666 258 329 184 112 373 494 1.007
Totale 18.021